Ticker Details
Eton Pharmaceuticals, Inc. Common Stock
IPO Date:	November 13, 2018
Sector:	Healthcare
Industry:	Drug Manufacturers - Specialty and Generic
Market Cap:	$1.81B
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.29 | 3.17%
Avg Daily Range (30 D):	$2.22 | 4.83%
Avg Daily Range (90 D):	$1.33 | 3.58%

Institutional Daily Volume
Avg Daily Volume:	.2M
Avg Daily Volume (30 D):	.54M
Avg Daily Volume (90 D):	.4M

Trade Size
Avg Trade Size (Sh.):	105
Avg Trade Size (Sh.) (30 D):	54
Avg Trade Size (Sh.) (90 D):	54

Institutional Trades
Total Institutional Trades:	227
Avg Institutional Trade:	$1.8M
Avg Institutional Trade (30 D):	$2.54M
Avg Institutional Trade (90 D):	$2.09M
Avg Institutional Trade Volume:	.08M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$1.97M
Avg Closing Trade (30 D):	$3.06M
Avg Closing Trade (90 D):	$2.14M
Avg Closing Volume:	88.51K

News

Aug 5, 2026 @ 10:50 AM Eton Pharmaceuticals Expands Infantile Hemangioma ... Source: Na

Aug 3, 2026 @ 10:50 AM Eton Pharmaceuticals to Report Second Quarter 2026... Source: Not Specified

Mar 2, 2026 @ 12:27 PM Eton Pharmaceuticals Expands Rare Disease Portfoli... Source: Globe Newswire

Feb 25, 2026 @ 6:47 PM Eton Pharmaceuticals Announces U.S. FDA Approval f... Source: Na

May 9, 2024 @ 8:01 PM Eton Pharmaceuticals Reports First Quarter 2024 Fi... Source: Eton Pharmaceuticals

Financials
	TTM	Q1 2026	Q4 2025
Basic EPS	$.42	$.06	$.06
Diluted EPS	$.35	$.05
Revenue	$37.59M	$24.27M	$21.28M
Gross Profit	$25.41M	$14.74M	$13.1M
Net Income / Loss	$11.58M	$1.55M	$1.48M
Operating Income / Loss	$12.79M	$2.41M	$2.46M
Cost of Revenue	$12.18M	$9.53M	$8.18M
Net Cash Flow	$7.18M	$-6.28M	$-11.18M
PE Ratio